← Back
$TNGX All transactions

Tango Therapeutics, Inc.

A

$ Value

$0

Shares

6,250

Price

$0

Filed

Jun 9

Insider

Name

Peters Malte

Title

CIK

0001876563

Roles

Director

Transaction Details

Transaction Date

2025-06-05

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,500

Footnotes

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. | This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Filing Info

Accession No.

0000950170-25-083912

Form Type

4

Issuer CIK

0001819133

Peters Malte's History

Date Ticker Type Value
2026-01-08 TNGX A $0
2026-01-08 TNGX A $0
2025-11-03 TNGX A $0
2025-08-19 HOOK $21K
2025-07-22 HOOK $27K
2025-06-05 TNGX A $0
2025-06-05 TNGX A $0

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$3.0M 2026-04-15